Home
Explore services
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
Responsive Menu
Home
Explore services
▼
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
▼
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
▼
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
LOGIN
Research Insights
Insights into value-based pricing approaches for oncology products in Germany
29 November 2024
Read More
Artificial intelligence in pharma access and pricing – will it take over from humans or enhance our understanding?
3 April 2024
Read More
Machine Learning for Value-Based Pricing
21 March 2024
Read More
Evolving Pharmaceutical Pricing: Dynamic Value-Based Models for Market Success
15 February 2024
Read More
The challenge of Healthcare Resource Use (HRU) Data in Low and Middle-Income Countries (LMICs)
6 February 2024
Read More
Predicting Price Erosion with Indication Expansion: A Deep Dive
1 February 2024
Read More
Harnessing the power of machine learning in market access & pricing
25 January 2024
Read More
Unlocking Pharma Dynamics: LoE Impact Analysis
5 January 2024
Read More
Predicting value and price of orphan drugs: a comparison across Europe and the US
5 January 2024
Read More
Yearly Archives
2025
2024
2023
2022
2021
Stay Informed
Sign up to receive the latest news and trends
straight into your inbox from GPI